English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, January 18, 2021
中国抗体SN1011之I期临床试验完成首例健康受试者给药
中國抗體SN1011之I期臨床試驗完成首例健康受試者給藥
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China
Monday, November 23, 2020
中国抗体内地总部建设正式开工
中國抗體內地總部建設正式開工
SinoMab Commenced Construction of its China Headquarters
Thursday, July 23, 2020
中国抗体与D2M建立战略合作关系
中國抗體與D2M建立戰略合作關係
SinoMab entered into Strategic Collaboration with D2M
Wednesday, June 10, 2020
中国抗体全球首创SM03于EULAR年会发表研究成果

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575